http://www.celldex.com
Celldex Therapeutics, Inc. Company Intro
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate.
Industry
Healthcare
Celldex Therapeutics, Inc. Headquaters
Perryville III Building
Hampton,08827
United States
Celldex Therapeutics, Inc. Share price
14 Sep 2022 08:55 GMT
$30.58
-1.0 (-3.17 %)
Celldex Therapeutics, Inc. Market cap
$1.413 B
WMC RANKING
2023
Celldex Therapeutics, Inc. # 213
BiotechnologyLatest Celldex Therapeutics, Inc. News
29 Mar 2023
2023-03-29 | NDAQ:CLDX | Press Release | Celldex ...
About Celldex Therapeutics, Inc. Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address...
29 Mar 2023
Glioblastoma Multiforme Treatment (GBM) Market to reach a ...
AbbVie Inc., Activartis GmbH, Agenus Inc., Arog Pharmaceuticals Inc., Bristol-Myers ... Celldex Therapeutics Inc., CTI BioPharma Corporation (formerly Cell...
29 Mar 2023
Infection Control Market: Type, End User, Geography, Drivers ...
Infection Control Market: Type, End User, Geography, Drivers ...
WMC Market Score
WMC Market to Revenue Score
Celldex Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Celldex Therapeutics, Inc. | USD | $5,375 | $58,470 | $-63,693 | $14,130B | 213 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Celldex Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Celldex Therapeutics, Inc. Post vs Top 4 Industry Competitors
Celldex Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Celldex Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Celldex Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Celldex Therapeutics, Inc. | 0.06 | 3.24 | 0 | 0 | 0 | 0 | 1.46 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
